Table 3

Multinomial logistic analysis

RIF

Survival

OR (CI)

p Value

OR (CI)

p Value

Control group:

Non-diabetics

Aprotinin

0.9 (0.4 to 2.2)

0.79

2.3 (0.5 to 11.2)

0.30

ACE inihibitors

1.0 (0.6 to 1.8)

0.94

0.7 (0.2 to 2.8)

0.60

Transfusion

0.9 (0.5 to 1.7)

0.79

0.8 (0.1 to 5.9)

0.69

Diabetics

Aprotinin

0.9 (0.3 to 2.8)

0.94

0.5 (0.2 to 1.4)

0.32

ACE inihibitors

1.4 (0.5 to 3.6)

0.52

12.6 (1.4 to 109.2)

0.02

Transfusion

1.6 (0.5 to 5.9)

0.4

0.7 (0.07 to 7.3)

0.77

Insulin group:

Non-diabetics

Aprotinin

0.7 (0.4 to 1.1)

0.14

2.0 (0.5 to 9.7)

0.39

ACE inihibitors

0.4 (0.3 to 0.5)

0.001

0.7 (0.2 to 3.1)

0.70

Transfusion

0.7 (0.5 to 1.1)

0.15

1.0 (0.6 to 2.9)

0.58

Diabetics

Aprotinin

1.0 (0.3 to 2.8)

0.97

1.7 (0.3 to 5.8)

0.26

ACE inihibitors

1.2 (0.7 to 2.3)

0.65

3.4 (1.2 to 12.3)

0.001

Transfusion

1.5 (0.8 to 3.0)

0.25

1.0 (0.8 to 1.1)

0.92

ACE, angiotensin-converting enzyme; CI, confidence interval; OR, odds ratio; RIF, renal failure according to RIFLE (Risk of renal failure, Injury to kidney function, Failure of kidney function, Loss of kidney function and End-stage renal failure) score criteria.

Lecomte et al. Critical Care 2008 12:R154   doi:10.1186/cc7145